Tuberculosis Vaccine Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tuberculosis Vaccine Program. Real-time updates on events, politics, business and more.

BioNTech SE: BioNTech Announces First Quarter 2023 Financial Results and Corporate Update

May 8, 2023

COVID-19 vaccine franchise focused on vaccine adaptation readiness ahead of the fall season and advancing next generation vaccine candidates and combinationsBioNTech and partner OncoC4 plan to start a

United Kingdom United States Ugur Sahin Jens Holstein Fosun Pharma European Commission

Source: finanznachrichten.de

Investegate |BioNTech SE Announcements | BioNTech SE: BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

March 30, 2022

Investegate announcements from BioNTech SE, BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

United States Sanofi Libtayo Fosun Pharma Sylke Maas Biontech Ribomabs Biontech Ribomab

Source: investegate.co.uk

BioNTech SE: BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

March 30, 2022

Fourth quarter and full year revenues of €5.5 billion1 and €19.0 billion1, respectivelyFull year net income of €10.3 billion and fully diluted earnings per share of €39.63 ($46.872)Expect to authorize